Saad Shakir
0000-0002-4084-297X
2 papers found
Refreshing results…
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice
Missing publications? Search for publications with a matching author name.